INTRODUCTION
Children are particularly vulnerable to the adverse effects of second-hand smoke which has been linked to a range of adverse outcomes during early-life including stillbirth, preterm birth, low birthweight, congenital anomalies, neonatal and infant mortality, asthma, respiratory infections and development of non-communicable disease in later life. Smoking causes more than 5 million deaths every year; an effective tobacco control is a key instrument to increase good conditions. A 2012 meta-analysis showed a 15% reduction in cardiovascular events and a 24% reduction in admissions to hospital for respiratory diseases after introduction of smoke-free legislation. We investigate if smoke-free laws can effectively reduce second-hand smoke exposure and improve population health. The goal is to inform national and international policy decisions on implementation of smoke-free legislation.
METHODS
We followed the methods detailed in a peer-reviewed systematic review protocol. We searched online databases of medical literature for published studies from January,1975 (first regional smoking ban, Minnesota, USA), to May, 2013, and the overarching WHO International Clinical Trials Registry Platform to identify unpublished work relevant to the research question. We did not apply any language restriction. Studies must investigate the association between introduction of a smoking ban in workplaces or public places, or both, and must have one or more prespecified health outcomes in children. We focused on children aged 12 years or younger to minimise potential confounding by self-smoking. Primary outcomes were stipulated a priori as preterm birth, low birthweight, and asthma. Secondary outcomes included various perinatal mortality indicators, very preterm birth, very low birthweight, small for gestational age, congenital anomalies, bronchopulmonary dysplasia, upper and lower respiratory infections, otitis media with effusion, wheezing, and chronic cough. Searches were done independently by two reviewers, and final study selection was based on consensus between both reviewers and, if necessary, independent arbitration. Risk of bias was assessed with EPOC quality criteria. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Effect estimates were pooled with random-effects metaanalysis.
RESULTS
We identified 11 eligible studies, reported between 2008 and 2013: eight published papers and three online reports. There were five North American studies describing effects of district-wide or state-wide bans, and six European studies investigating the effect of national bans. Four studies described the effect on pediatric asthma, whereas all other studies reported on perinatal outcomes. All studies were classified as interrupted time series. Four studies were deemed to have low risk of bias, six had moderate, and one had high. According to preterm birth and hospital attendance because of asthma, meta-analysis showed smoke-free legislation to be associated with a clinically important and statistically significant drop. No statistically significant results about a reduction of low birthweight after smoke-free legislation. Possibly, the risk reduction of preterm birth at the population level attributed to smoking bans is not large enough to translate into an effect on population birthweight.
DISCUSSION
This systematic review and meta-analysis presents strong evidence supporting the effectiveness of smoke-free legislation to improve clinically important perinatal and child health outcomes. Rates of both preterm birth and pediatric hospital admissions for asthma were reduced by 10% after its introduction. This article adds important information from an early-life perspective to the growing evidence base supporting the mandate for worldwide implementation of smoke-free legislation as a means to improve population health and for children but also for adults health benefit. Causality is further supported by a dose-response effect for most outcomes. Many studies have identified that smoking bans effectively reduce maternal smoking during pregnancy and secondhand smoke exposure during childhood. The proportion of smoke-free homes increased in several countries after smoke-free laws. The health benefit in children is likely to be mediated through these reductions in antenatal and postnatal second-hand smoke exposure. The public health effect of smoke-free legislation on perinatal and pediatric health is considerable. Introducing smoke-free legislation, a possible 10% preterm birth reduction is promising, instead of 5% created by the five most effective preventive approaches provided in high-income countries. Moreover smoke free-legislation seems to be a cost-effective population intervention in view of the magnitude of its public health benefits and the established absence of adverse economic effects that have long been claimed by the tobacco industry. Formal cost-effectiveness studies are, however, needed to further substantiate this notion. Despite the emerging evidence for early-life health benefits associated with smoke-free legislation, several knowledge gaps remain. We were unable to identify any studies from low-income or middle-income countries, where the highest burden of early-life adverse outcomes lies; indeed findings from high-income countries might not easily be globally generalisable. Additional studies would furthermore help to expand the present evidence base, which is now centred on a small number of studies and other outcomes have to be studied (respiratory tract infections, SIDS and early life mortality). It is now evident that early-life protection from involuntary second-hand smoke exposure holds great potential to reduce the consequential disease burden and associated economic losses posed to society (although the exact mechanisms by which smoke-free legislation exerts its effect are unknown). Smoke-free public environments on a national level should be regarded as an integral part of public health strategy to further reduce the worldwide burden of disease associated with smoking.
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